Financiere de Tubize SA operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Financiere de Tubize SA with three other
pharmaceutical manufacturers in Europe:
sales of 113.04 million Euro [US$123.94 million]
of which 92%
was Commercialized Vaccines),
Laboratorios Farmaceuticos Rovi S.A.
(303.20 million Euro [US$332.46 million]
of which 82%
was Marketing), and
based in the United Kingdom
(£233.20 million [US$284.74 million]
of which 100%
was Antibodies & Related Products).
Financiere de Tubize SA reported sales of 288.25 million Euro (US$316.06 million)
December of 2018.
increase of 5.9%
versus 2017, when the company's sales were 272.23 million Euro.